Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-002166

Chief Technology Officer sold 1,514 shares at $5.37 ($8,129)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Binder-Scholl Gwendolyn Knowlton Chief Technology Officer 2019-01-14 Sale −1,514 $5.37 $8,129 2,487 D: show line 1 in the form
Open-market sales · 1,514 sh · avg $5.37 · $8,129
Loading xslF345X03/a4.xml…